Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Healthcare CoSAU:4009 -1.56%76 PS Ratio is 0.93 as of Aug. 07, 2026, which is 53% below its 10-year median of 1.99. GuruFocus rates SAU:4009 with a GF Score™ of 76/100 and a GF Value™ of ﷼80.45 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Middle East Healthcare Co ranks better than 66.46% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Middle East Healthcare Co's share price is ﷼31.50.
Middle East Healthcare Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼34.05. Hence, Middle East Healthcare Co's PS Ratio for today is 0.93.
Good Sign:
Middle East Healthcare Co stock PS Ratio (=0.89) is close to 10-year low of 0.89.
The historical rank and industry rank for Middle East Healthcare Co's PS Ratio or its related term are showing as below:
SAU:4009'
s PS Ratio Range Over the Past 10 Years
Min: 0.88 Med: 1.99 Max: 16.16
Current: 0.89
During the past 11 years, Middle East Healthcare Co's highest PS Ratio was 16.16. The lowest was 0.88. And the median was 1.99.
SAU:4009's PS Ratio is ranked better than 66.46% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs SAU:4009: 0.89
During the past 12 months, the average Revenue per Share Growth Rate of Middle East Healthcare Co was 7.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.30% per year.
During the past 11 years, Middle East Healthcare Co's highest 3-Year average Revenue per Share Growth Rate was 15.50% per year. The lowest was -3.20% per year. And the median was 11.65% per year.
Middle East Healthcare Co (SAU:4009) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Middle East Healthcare Co PS Ratio Related Terms
Middle East Healthcare Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Middle East Healthcare Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Middle East Healthcare Co's Share Price of today is ﷼31.50. Middle East Healthcare Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼34.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Middle East Healthcare Co (SAU:4009) has a PS Ratio of 0.93 as of Aug. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Middle East Healthcare Co and its competitors. This is 53% below median its historical median of 1.99. Over the past decade, Middle East Healthcare Co's PS Ratio has ranged from 0.88 to 16.16. According to the industry distribution chart, Middle East Healthcare Co ranks #220 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 33.5%.
Is Middle East Healthcare Co's PS Ratio too high?
Middle East Healthcare Co's current PS Ratio of 0.93 is 53% below median its 10-year median of 1.99. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 16.16. The Healthcare Providers & Services industry median PS Ratio is 1.52. Middle East Healthcare Co's value of 0.93 is 38.8% below this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #220 out of 656 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Middle East Healthcare Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #220 out of 656 companies for PS Ratio. This puts Middle East Healthcare Co in the upper half of its industry. The industry median PS Ratio is 1.52. Middle East Healthcare Co's value of 0.93 is 38.8% below this benchmark. Historically, Middle East Healthcare Co's own PS Ratio has ranged from 0.88 to 16.16 over the past decade. While the company's 10-year median is 1.99 vs. the industry median of 1.52, Middle East Healthcare Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current PS Ratio of 0.93 is 38.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current PS Ratio is 0.93, which is 53% below median its own 10-year median of 1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.45, compared to a current price of ﷼31.50 — trading 60.8% below its estimated fair value. The current PS Ratio is 0.93, which is 53% below median its 10-year median of 1.99 and 38.8% below the Healthcare Providers & Services industry median of 1.52. Middle East Healthcare Co's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current PS Ratio is 0.93 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼31.50 is trading 60.8% below its estimated GF Value™ of ﷼80.45.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
PS Ratio: 0.93 (53% below median its 10-year median of 1.99)
GF Value™: ﷼80.45 vs. price of ﷼31.50 (60.8% below fair value)
Industry Position: 38.8% below the Healthcare Providers & Services median (#220 of 656)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
76GF Score
Get the complete analysis for SAU:4009
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
